Search
Returning search results with filters:
Remove filter for
Issue: Health products
Remove filter for
Last updated: 2022
Clear all
Type
Audience
Category
Issue
Last updated
- (-) 2022
- December 202210 results available
- November 20227 results available
- October 202210 results available
- September 202213 results available
- August 202220 results available
- July 202211 results available
- June 202213 results available
- May 202210 results available
- April 20229 results available
- March 202213 results available
- February 202212 results available
- January 20229 results available
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.
Displaying 1 - 15 of 137 items.
Gas cylinders containing commercial grade oxygen instead of medical grade oxygen were delivered to homecare customers.
RecallHealth product recall | 2022-12-22
The concentration of the medicinal ingredient, sodium fluoride, is out of specification in the affected lot.
RecallHealth product recall | 2022-12-15
Affected lot may result in a false negative for skin test (peanut allergy).
RecallHealth product recall | 2022-12-14
Product sterility may be compromised in the affected lot.
RecallHealth product recall | 2022-12-14
On December 9, 2022, Health Canada authorized a new formulation of the bivalent vaccine, COMIRNATY Original & Omicron BA.4/BA.5, as a booster dose for active immunization against coronavirus disease 2019 (COVID-19) caused by severe acute respiratory…
AlertHealth professional risk communication | 2022-12-09
Affected lot contains active ingredient (Cholecalciferol) levels outside of the labelled claim.
RecallHealth product recall | 2022-12-08
The colour is out of specification in the affected lot(s).
RecallHealth product recall | 2022-12-06
OCALIVA received a Notice of Compliance with Conditions in May 2017 for the treatment of PBC, pending the results of trials to verify its clinical benefit.
OCALIVA is now contraindicated for PBC patients with advanced disease, such as those with Child…
AlertHealth professional risk communication | 2022-12-05
Affected lots may contain the presence of foreign matter.
RecallHealth product recall | 2022-12-05
Affected lot being voluntarily recalled due to a series of adverse reactions.
RecallHealth product recall | 2022-12-01
GlaxoSmithKline Consumer Healthcare ULC is recalling one lot of TUMS Peppermint Regular Strength tablets after some tablets were found to contain fragments of fibreglass and other material, including paper and aluminum foil. The product is sold in a…
AlertPublic advisory | 2022-11-30
Affected lot has incorrect product image on the product label.
RecallHealth product recall | 2022-11-21
Health Canada authorized SPIKEVAX Bivalent (Original / Omicron BA.4/5) (elasomeran/davesomeran) on November 3, 2022. In order to provide rapid access to the vaccine, Moderna will distribute product vials and cartons labelled in English only with the…
AlertHealth professional risk communication | 2022-11-18
Affected lot may result in a false negative for skin test (peanut allergy)
RecallHealth product recall | 2022-11-15
Intravenous bag may be leaking in affected lots.
RecallHealth product recall | 2022-11-03